Company Filing History:
Years Active: 2015
Title: Dhamodharan Neelamegan: Innovator in Enzymatic Degradation for Vaccine Development
Introduction
Dhamodharan Neelamegan is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel enzymes and processes that have implications for vaccine production and combating gram-negative bacteria.
Latest Patents
Neelamegan holds a patent for the "Enzymatic degradation of lipid A fatty acids of bacterial LPS." This innovative work describes novel enzymes, processes, and antigenic structures that are useful in producing vaccines. The patent outlines how enzymes isolated from slime molds can specifically degrade lipopolysaccharide (LPS). This enzymatic degradation allows for the preservation of immunogenic epitopes of the core oligosaccharide portion of the LPS molecule while removing fatty acids from the lipid A region.
Career Highlights
Dhamodharan Neelamegan is affiliated with the National Research Council of Canada, where he continues to advance research in enzymatic processes. His work is pivotal in the development of new strategies for vaccine production, particularly against gram-negative bacterial infections.
Collaborations
Neelamegan has collaborated with esteemed colleagues such as Andrew Cox and Ian C Schoenhofen. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the field.
Conclusion
Dhamodharan Neelamegan's innovative work in enzymatic degradation represents a significant advancement in vaccine development and the fight against bacterial infections. His contributions continue to influence the biotechnology landscape positively.